Profound Medical Corp. (PROF)
| Market Cap | 204.15M |
| Revenue (ttm) | 5.68M |
| Net Income (ttm) | -18.16M |
| Shares Out | 21.00M |
| EPS (ttm) | -1.39 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 68,055 |
| Open | 9.50 |
| Previous Close | 9.49 |
| Day's Range | 9.26 - 9.80 |
| 52-Week Range | 9.26 - 28.97 |
| Beta | 1.55 |
| Analysts | Strong Buy |
| Price Target | 26.52 (+172.8%) |
| Earnings Date | n/a |
About PROF
Profound Medical Corp., together with its subsidiaries, operates as a medical technology company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with me...
Analyst Forecast
According to 8 analysts, the average rating for PROF stock is "Strong Buy." The 12-month stock price forecast is 26.52, which is an increase of 172.84% from the latest price.
News
Profound Medical Announces First Patients Treated in Prospective, Randomized Clinical Trial Comparing the TULSA Proce...
TORONTO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...
Kenneth Knudson Joins Profound Medical as Chief Commercial Officer
TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...
Profound Medical (PROF) Reports Q3 Loss, Lags Revenue Estimates
Profound Medical (PROF) delivered earnings and revenue surprises of -11.54% and -36.58%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Profound Medical Announces Third Quarter 2021 Financial Results
TORONTO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...
Profound Medical to Participate in November Virtual Investor Conferences
TORONTO, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...
Will Profound Medical (PROF) Report Negative Earnings Next Week? What You Should Know
Profound Medical (PROF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Profound Medical to Release Third Quarter 2021 Financial Results on November 4 – Conference Call to Follow
TORONTO, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...
Profound Medical to Participate in September Virtual Investor Conferences
TORONTO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable,...
PROFOUND MEDICL (PROF) Reports Q2 Loss, Tops Revenue Estimates
PROFOUND MEDICL (PROF) delivered earnings and revenue surprises of -34.62% and 15.98%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Profound Medical Announces Second Quarter 2021 Financial Results
TORONTO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...
PROFOUND MEDICL (PROF) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
PROFOUND MEDICL (PROF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Profound Medical to Participate in A.G.P.'s Virtual MedTech Summer Conference
TORONTO, July 22, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...
Profound Medical to Release Second Quarter 2021 Financial Results on August 4 – Conference Call to Follow
TORONTO, July 15, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...
Profound Medical to Participate in June Investor Conferences
TORONTO, May 25, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable,...
Profound Medical Announces Voting Results from the 2021 Annual Meeting of Shareholders and Management Changes
TORONTO, May 19, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual Meeting of Shareholders ...
Profound Medical Announces First Quarter 2021 Financial Results
TORONTO, May 12, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, i...
Analysts Estimate PROFOUND MEDICL (PROF) to Report a Decline in Earnings: What to Look Out for
PROFOUND MEDICL (PROF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Profound Medical to Release First Quarter 2021 Financial Results on May 12 – Conference Call to Follow
TORONTO, April 21, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable,...
Profound Medical to Participate in the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference
TORONTO, April 14, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable...
Profound Medical Announces the Appointment of Cynthia Lavoie to its Board of Directors
TORONTO, March 03, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free th...
PROFOUND MEDICL (PROF) Reports Q4 Loss, Lags Revenue Estimates
PROFOUND MEDICL (PROF) delivered earnings and revenue surprises of -40.74% and -4.95%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Profound Medical Announces Fourth Quarter and Full Year 2020 Financial Results
TORONTO, March 02, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable,...
Profound Medical to Participate in March Virtual Investor Conferences
TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free the...
Profound Medical to Participate in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Confer...
TORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free the...
Profound Medical to Release Fourth Quarter and Full Year 2020 Financial Results on March 2 – Conference Call to Follow
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free the...